The Connecting Care With Clicks 2024 conference is set to bring together leading healthcare professionals to discuss the future of digital marketing in the industry. Organised by Medical Channel Asia, the fastest growing digital health media platform in Southeast Asia, the conference will take place on October 12, 2024 in Kuala Lumpur, Malaysia.
Hundreds of doctors and healthcare professionals are attending the one-day event to gain insights into utilizing innovative digital strategies and technologies to engage patients. With insightful keynote presentations from prominent figures like Dr. Mahesh Appannan of the Malaysian Ministry of Health and viral healthcare social media influencers such as Dato’ Dr. Tikfu Gee, this conference will proof to be a fruitful session to those looking to establish their digital presence and influence health conversations in their online communities.
A total of 376 Indonesian hajj pilgrims have died, with most of them caused by heat stroke. This alarming trend highlights the health and safety conditions of the pilgrims during the Hajj season.
Roche announced today that Tecentriq® SC (atezolizumab) has been approved by the Singapore Health Sciences Authority (HSA) for all indications in which the intravenous (IV) formulation of Tecentriq has been previously approved, including certain types of lung, breast and liver cancer.4 Tecentriq SC is Roche’s fourth subcutaneous cancer therapy,5-7 and the world’s first injectable anti-PD-(L)1 cancer immunotherapy.
